{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "adds_modification",
    "modifications" : [ {
      "modification_type" : "phosphorylation"
    } ],
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "be:PKC",
      "entity_text" : "PKC",
      "entity_type" : "family"
    },
    "is_direct" : false,
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:Q96RJ0",
      "entity_text" : "TAAR1",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "TAAR1 agonist treatment of striatal or thalamic synaptosomes promotes changes in DAT / SERT and NET kinetic activity, respectively, by promoting PKA and PKC phosphorylation cascades, XREF_BIBR, XREF_BIBR so it is likely that TAAR1 expressed in other brain regions can also promote PKA and PKC signaling cascades upon stimulation.",
  "reading_complete" : "2020-08-05T20:04:42Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T20:01:08Z",
  "trigger" : "promotes",
  "evidence" : [ "TAAR1 agonist treatment of striatal or thalamic synaptosomes promotes changes in DAT/SERT and NET kinetic activity, respectively, by promoting PKA and PKC phosphorylation" ],
  "pmc_id" : "3682756",
  "score" : 0
}